1 Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. david.tamborero@ki.se.
2 Medical Oncology-Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
3 Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
4 Cancer Research UK Cambridge Centre, Cambridge, UK.
5 Medical Oncology Department, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
6 Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
7 Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
8 Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
9 Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
10 NCT Trial Center, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.
11 Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
12 IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
13 Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
14 Research Coordination Area, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
15 Gustave Roussy Cancer Campus Grand Paris, Villejuif, France Cancer Core Europe, Villejuif, France.
16 Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany.
17 German Cancer Consortium, Heidelberg, Germany.
18 Scientific Directorate, Princess Máxima Center, Utrecht, the Netherlands.
19 Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
20 Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
21 Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
22 Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, UVic-UCC, Barcelona, Spain.
23 Investigational Cancer Therapeutics Department, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
24 Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. janne.lehtio@ki.se.